BVF Inc
- SEC CIK
- 0001056807
- 最新申報
- 2026/8/14
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 80
- 較 2022 年第 2 季 +1
- 總值
- $24.2 億
- 較 2022 年第 2 季 +$3.50 億 (+16.9%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 21,751,284 | $1.73 億 | 7.2% | 00.0% | 不變 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 2,872,953 | $1.27 億 | 5.2% | +1,596,379+125.1% | 加碼 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 9,275,158 | $1.08 億 | 4.5% | 00.0% | 不變 | 歷史 |
| KYMRKymera Therapeutics, Inc. | COM | 4,692,604 | $1.02 億 | 4.2% | +553,846+13.4% | 加碼 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 8,291,988 | $1.01 億 | 4.2% | 00.0% | 不變 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 4,339,521 | $9,708 萬 | 4.0% | −45,284−1.0% | 減碼 | 歷史 |
| CGEMCullinan Therapeutics, Inc. | COM | 7,509,059 | $9,627 萬 | 4.0% | 00.0% | 不變 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 2,078,220 | $7,694 萬 | 3.2% | +419,000+25.3% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,678,947 | $7,226 萬 | 3.0% | 00.0% | 不變 | 歷史 |
| RCUSArcus Biosciences, Inc. | COM | 2,717,020 | $7,108 萬 | 2.9% | −1,243,928−31.4% | 減碼 | 歷史 |
| MRUSMerus N.V. | COM | 3,444,420 | $6,899 萬 | 2.8% | −637,011−15.6% | 減碼 | 歷史 |
| THRDThird Harmonic Bio, Inc. | COM | 3,501,814 | $6,643 萬 | 2.7% | +3,501,814 | 新進 | 歷史 |
| XOMAXOMA Royalty Corp | COM NEW | 3,611,494 | $6,468 萬 | 2.7% | +80,951+2.3% | 加碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 3,255,588 | $6,420 萬 | 2.7% | +1,000,000+44.3% | 加碼 | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 3,976,543 | $6,259 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| CTICCti Biopharma Corp | COM | 8,813,021 | $5,129 萬 | 2.1% | −116,669−1.3% | 減碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 3,294,859 | $4,916 萬 | 2.0% | +500,000+17.9% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 3,203,783 | $4,376 萬 | 1.8% | 00.0% | 不變 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 5,590,048 | $4,321 萬 | 1.8% | +2,222,222+66.0% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 1,798,085 | $4,321 萬 | 1.8% | −558,849−23.7% | 減碼 | 歷史 |
| CINCCinCor Pharma, Inc. | COM | 1,312,443 | $4,307 萬 | 1.8% | −331,950−20.2% | 減碼 | 歷史 |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 16,149,179 | $3,876 萬 | 1.6% | +2,000,000+14.1% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,741,840 | $3,573 萬 | 1.5% | −2,172−0.1% | 減碼 | 歷史 |
| ITOSiTeos Therapeutics, Inc. | COM | 1,810,835 | $3,450 萬 | 1.4% | −118,366−6.1% | 減碼 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 901,095 | $3,253 萬 | 1.3% | −696,871−43.6% | 減碼 | 歷史 |
| NUVLNuvalent, Inc. | COM | 1,666,282 | $3,239 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 4,007,413 | $3,222 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 2,084,824 | $3,111 萬 | 1.3% | −172,350−7.6% | 減碼 | 歷史 |
| ALLKAllakos Inc. | COM | 5,006,921 | $3,064 萬 | 1.3% | +5,006,921 | 新進 | 歷史 |
| EQRXEQRx, Inc. | COM | 6,008,187 | $2,974 萬 | 1.2% | −4,640,340−43.6% | 減碼 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 1,616,665 | $2,810 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 6,894,345 | $2,772 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| CNCEConcert Pharmaceuticals, Inc. | COM | 3,629,000 | $2,431 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 7,428,379 | $2,347 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ANNXAnnexon, Inc. | COM | 3,780,694 | $2,337 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 650,000 | $2,233 萬 | 0.9% | +650,000 | 新進 | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 2,472,327 | $2,173 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 7,611,503 | $2,101 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 1,470,334 | $1,991 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| STROSutro Biopharma, Inc. | COM | 3,447,946 | $1,914 萬 | 0.8% | 00.0% | 不變 | 歷史 |
| ETNB89bio, Inc. | COM | 3,143,682 | $1,820 萬 | 0.8% | −754,318−19.4% | 減碼 | 歷史 |
| Rain Oncology Inc.75082Q105 | COM | 3,526,729 | $1,721 萬 | 0.7% | 00.0% | 不變 | – |
| VSTMVerastem, Inc. | COM | 19,974,658 | $1,698 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,813,633 | $1,650 萬 | 0.7% | +1,813,633 | 新進 | 歷史 |
| REPLReplimune Group, Inc. | COM | 926,529 | $1,600 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 8,748,629 | $1,592 萬 | 0.7% | +5,050,000+136.5% | 加碼 | 歷史 |
| VIRXViracta Therapeutics, Inc. | COM | 3,614,662 | $1,544 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,508,416 | $1,489 萬 | 0.6% | +841,750+126.3% | 加碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 6,851,051 | $1,261 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| WHWKWhitehawk Therapeutics, Inc. | COM | 879,085 | $1,242 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $1,133 萬 | 0.5% | 00.0% | 不變 | – |
| CTMXCytomX Therapeutics, Inc. | COM | 6,595,801 | $956.4 萬 | 0.4% | +792,101+13.6% | 加碼 | 歷史 |
| IMAImageneBio, Inc. | COM | 2,503,071 | $888.6 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,135,940 | $817.9 萬 | 0.3% | −139,300−10.9% | 減碼 | 歷史 |
| INFIInfinity Pharmaceuticals, Inc. | COM | 6,353,645 | $756.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| HLVXHilleVax, Inc. | COM | 382,452 | $653.6 萬 | 0.3% | −610.0% | 減碼 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 2,326,710 | $642.2 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,080,320 | $584.2 萬 | 0.2% | 00.0% | 不變 | – |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 2,938,851 | $579.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $526.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CDTXCidara Therapeutics, Inc. | COM | 6,861,127 | $430.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SPROSpero Therapeutics, Inc. | COM | 1,929,376 | $385.9 萬 | 0.2% | −1,160,239−37.6% | 減碼 | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 4,996,565 | $374.6 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| MOLNMolecular Partners AG | ADS | 443,221 | $297.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| IVAInventiva S.A. | ADS | 686,040 | $265.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 2,312,200 | $261.3 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| RNACCartesian Therapeutics, Inc. | COM | 1,391,749 | $228.2 萬 | 0.1% | −331,384−19.2% | 減碼 | 歷史 |
| GBIOGeneration Bio Co. | COM | 361,824 | $192.1 萬 | 0.1% | −1,194,208−76.7% | 減碼 | 歷史 |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 513,791 | $151.6 萬 | 0.1% | 00.0% | 不變 | – |
| XFORX4 Pharmaceuticals, Inc | COM | 847,879 | $145.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CALACalithera Biosciences, Inc. | COM NEW | 464,742 | $136.6 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| LITSLite Strategy, Inc. | COM NEW | 3,532,057 | $136.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,370,947 | $112.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RNTXRein Therapeutics, Inc. | COM | 5,265,555 | $108.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ELTXElicio Therapeutics, Inc. | COM | 1,071,297 | $98.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Erytech Pharma29604W108 | SPONSORED ADR | 1,314,656 | $69.0 萬 | <0.1% | 00.0% | 不變 | – |
| BNOXBionomics Ltd | ADS | 80,971 | $57.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,799,694 | $55.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $52.3 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| CFRXCONTRAFECT Corp | COM NEW | 472,300 | $7.90 萬 | <0.1% | −3,500,000−88.1% | 減碼 | 歷史 |
2022 年第 2 季之後清倉（3 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。